Industry guide
Biopharma in Chengdu
Chengdu's biopharma cluster — drug discovery, CRO/CDMO services and medical devices — and the opportunities for foreign partners and investors.
Sources (1)
- Chengdu high-tech / biopharma park profiles
Upstream
Research & discovery
University labs, reagents
Talent & IP
Life-science graduates, patents
Midstream
CRO / CDMO
Preclinical, clinical and manufacturing services
Medical devices
Device design and manufacturing
Downstream
Clinical & market
Hospitals, distribution, market access
Why Chengdu for biopharma
Chengdu combines research talent, services and manufacturing across the biopharma value chain within dedicated parks.
The value chain
From discovery and talent upstream, through CRO/CDMO and devices, to clinical and market access downstream — the map shows where you can plug in.
How foreign companies engage
- CRO/CDMO partnerships for cost-efficient development and manufacturing.
- Joint R&D with universities.
- Device manufacturing and licensing.
For which audiences
Asian and European biopharma and medical-device companies.
Key companies & anchors
-
Chengdu biopharma parks and CRO/CDMO firms
TODO: confirm named anchors
Most relevant for: Asia · Europe
Frequently asked questions
- What is Chengdu's strength in biopharma?
- A combination of life-science research talent, CRO/CDMO services and medical-device manufacturing, supported by dedicated parks.
- How do foreign biopharma companies typically engage?
- Through CRO/CDMO partnerships, joint R&D with universities, licensing, or device manufacturing. See our Talent & R&D guides for university matches.
- Is the talent local?
- Sichuan University and other institutions supply life-science graduates; see Talent & R&D.